Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Finn Egil Skjeldestad
ResearcherPublications, citations & collaboration network
Finn Egil Skjeldestad is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 241 works, 7,953 citations, an h-index of 37 and an i10-index of 115.
241
Works
7,953
Citations
37
h-index
115
i10-index
How has Finn Egil Skjeldestad's publication output changed over time?
ScholarIQpublication output · 1996–2016
Output grew0% over the shown period — from 1 works in 1996 to 1 in 2016.
1
1
1
1
1
1
2
1
1
1
1996199920052006200720082011201220152016
What are the most-cited papers on Finn Egil Skjeldestad?
ScholarIQmost cited works
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, Rosíres Pereira de Andrade, Kevin A. Ault, Anna R. Giuliano, Cosette M. Wheeler, Laura A. Koutsky, Christian Malm, Matti Lehtinen, Finn Egil Skjeldestad, Sven-Eric Olsson, Margareta Steinwall, Darron R. Brown, Robert J. Kurman, Brigitte M. Ronnett, Mark H. Stoler, Alex Ferenczy, Diane M. Harper, Gretchen Tamms, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Frank J. Taddeo, Kathrin U. Jansen, Mark T. Esser, Heather L. Sings, Alfred J. Saah, Eliav Barr
The Lancet Oncology. 20051,580 Citations
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
Øjvind Lidegaard, Lars Nielsen, Charlotte Wessel Skovlund, Finn Egil Skjeldestad, Ellen Løkkegaard
BMJ. 2011614 CitationsOPEN ACCESS
Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study
Anne Flem Jacobsen, Finn Egil Skjeldestad, Per Morten Sandset
American Journal of Obstetrics and Gynecology. 2007475 Citations
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, Rosíres Pereira de Andrade, Darron R. Brown, Alex Ferenczy, Diane M. Harper, Laura A. Koutsky, Robert J. Kurman, Matti Lehtinen, Christian Malm, Sven-Eric Olsson, Brigitte M. Ronnett, Finn Egil Skjeldestad, Margareta Steinwall, Mark H. Stoler, Cosette M. Wheeler, Frank J. Taddeo, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Rocio D. Marchese, Mark T. Esser, Janine T. Bryan, Kathrin U. Jansen, Heather L. Sings, Gretchen Tamms, Alfred J. Saah, Eliav Barr
Vaccine. 2006470 Citations
Ante- and postnatal risk factors of venous thrombosis: a hospital-based case–control study
Anne Flem Jacobsen, Finn Egil Skjeldestad, Per Morten Sandset
S164469042. 2008402 Citations
Related on ScholarIQ
UiT The Arctic University of Norway
Institution
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Paper
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
Paper
Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study
Paper
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Paper
Ante- and postnatal risk factors of venous thrombosis: a hospital-based case–control study
Paper